These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24731391)

  • 1. [Usefulness of corrective make-up in children with vitiligo coordinated by dermatology nursing].
    Padilla-España L; Ramírez-López B; Fernández-Sánchez E
    Enferm Clin; 2014; 24(3):196-9. PubMed ID: 24731391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camouflage therapy workshop for pediatric dermatology patients: a review of 6 cases.
    Padilla-España L; del Boz J; Ramírez-López MB; Fernández-Sánchez ME
    Actas Dermosifiliogr; 2014 Jun; 105(5):510-4. PubMed ID: 24369988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrective camouflage in pediatric dermatology.
    Tedeschi A; Dall'Oglio F; Micali G; Schwartz RA; Janniger CK
    Cutis; 2007 Feb; 79(2):110-2. PubMed ID: 17388210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions.
    Ramien ML; Ondrejchak S; Gendron R; Hatami A; McCuaig CC; Powell J; Marcoux D
    J Am Acad Dermatol; 2014 Nov; 71(5):935-40. PubMed ID: 25218434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cosmetic Camouflage on the Quality of Life of Children With Skin Disease and Their Families.
    Salsberg JM; Weinstein M; Shear N; Lee M; Pope E
    J Cutan Med Surg; 2016 May; 20(3):211-5. PubMed ID: 26162859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camouflage for patients with vitiligo vulgaris improved their quality of life.
    Tanioka M; Yamamoto Y; Kato M; Miyachi Y
    J Cosmet Dermatol; 2010 Mar; 9(1):72-5. PubMed ID: 20367677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosmetic camouflage as an adjuvant to vitiligo therapies: Effect on quality of life.
    Bassiouny D; Hegazy R; Esmat S; Gawdat HI; Ahmed Ezzat M; Tawfik HA; Hegazy AA; Ibrahim S
    J Cosmet Dermatol; 2021 Jan; 20(1):159-165. PubMed ID: 32406129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camouflage for patients with vitiligo.
    Kaliyadan F; Kumar A
    Indian J Dermatol Venereol Leprol; 2012; 78(1):8-15. PubMed ID: 22199054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
    Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
    Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Vitiligo on Quality of Life.
    Morales-Sánchez MA; Vargas-Salinas M; Peralta-Pedrero ML; Olguín-García MG; Jurado-Santa Cruz F
    Actas Dermosifiliogr; 2017 Sep; 108(7):637-642. PubMed ID: 28456327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of corrective makeup in the management of patients in dermatology.
    Seité S; Deshayes P; Dréno B; Misery L; Reygagne P; Saiag P; Stengel F; Roguedas-Contios A; Rougier A
    Clin Cosmet Investig Dermatol; 2012; 5():123-8. PubMed ID: 23055760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects.
    Dertlioğlu SB; Cicek D; Balci DD; Halisdemir N
    Int J Dermatol; 2013 Jan; 52(1):96-101. PubMed ID: 23278616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases.
    Boehncke WH; Ochsendorf F; Paeslack I; Kaufmann R; Zollner TM
    Eur J Dermatol; 2002; 12(6):577-80. PubMed ID: 12459532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo: the psychosocial effects.
    Mason PJ
    Medsurg Nurs; 1997 Aug; 6(4):216-8, 232. PubMed ID: 9313549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo.
    Krüger C; Panske A; Schallreuter KU
    Int J Dermatol; 2014 Jan; 53(1):43-50. PubMed ID: 23692406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of vitiligo: patient characteristics associated with quality of life.
    Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
    J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Double Blind Clinical Trial on a Sabgh Formulation for Patients With Vitiligo.
    Hosseinkhani A; Montaseri H; Sodaifi M; Mohagheghzadeh A; Seradj H; Afshari-Jouybari H
    J Evid Based Complementary Altern Med; 2015 Oct; 20(4):254-8. PubMed ID: 25851025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review.
    Cadmus SD; Lundgren AD; Ahmed AM
    Pediatr Dermatol; 2018 Jul; 35(4):441-447. PubMed ID: 29766546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camouflage for vitiligo.
    Tanioka M; Miyachi Y
    Dermatol Ther; 2009; 22(1):90-3. PubMed ID: 19222521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.